Shares dip a day after Piramal Pharma’s Q2 FY25 earnings: revenue jumps 17 per cent, profit climbs 350 per cent

Net profit after tax of Piramal Pharma soared by 350 per cent Y-o-Y to ₹23 crore, benefiting from strong operational efficiency and strategic initiatives

Subscribe To Our Free Newsletter